Ellevest, Inc. Denali Therapeutics Inc. Transaction History

Ellevest, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$26.28 - $33.92 $3,127 - $4,036	119 New	119 $3,000
Q2 2022 Jul 18, 2022	SELL	$20.88 - $35.19 $62 - $105	-3 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$29.0 - $47.27 $232 - $378	-8 Reduced 72.73%	3 $0
Q4 2021 Jan 24, 2022	SELL	$42.59 - $55.02 $170 - $220	-4 Reduced 26.67%	11 $0
Q3 2021 Oct 19, 2021	SELL	$48.48 - $78.23 $678 - $1,095	-14 Reduced 48.28%	15 $1,000
Q2 2021 Jul 13, 2021	SELL	$50.3 - $78.44 $150 - $235	-3 Reduced 9.38%	29 $2,000
Q1 2021 May 03, 2021	BUY	$53.8 - $81.53 $269 - $407	5 Added 18.52%	32 $2,000
Q4 2020 Feb 04, 2021	BUY	$36.89 - $93.56 $590 - $1,496	16 Added 145.45%	27 $2,000
Q3 2020 Oct 26, 2020	BUY	$23.13 - $38.84 $254 - $427	11 New	11 $0
Q2 2020 Jul 06, 2020	SELL	$16.01 - $28.82 $528 - $951	-33 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$14.4 - $19.99 $475 - $659	33 New	33 $1,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.